Report of chronic myelogenous leukemia in chronic phase from, Asian Institute of Oncology, Mumbai, 2002-2010 by Shweta Bansal, S H Advani

Get full text

Consensus Guidelines for the Use of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in the Management of Hormone Receptor Positive (HR+ve), Her2−ve Early Breast Cancer (EBC) by Purvish M. Parikh, Amish Vora, Rajan Yadav, Akhil Kapoor, Tarini Sahoo, Senthil Rajappa, Govind Babu Kanakashetty, M. Vamshi Krishna, Ghanashyam Biswas, Ankur Bahl, Nikhil Ghadyalpatil, Thirumalairaj Raja, Jyoti Bajpai, Amol Akhade, Randeep Singh, Shyam Aggarwal, Maheboob Basade, S.H. Advani

Get full text

Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractor... by Dina M Flink, Se Jeong, Gavin Thurston, Rajat Bannerji, Vladimir Jankovic, Nathalie Fiaschi, Max S Topp, Jurriaan Brouwer-Visser, Raquel P Deering, Kamil J Cygan, Darius Scott, Lauren Boucher, Namita T Gupta, Suraj Gupta, Christina Adler, Johannes Duell, Ranjana H Advani, Aafia Chaudhry, Srikanth R Ambati

Get full text

Current treatment options for human epidermal growth factor receptor 2-directed therapy in metastatic breast cancer: An Indian perspective by Gupta Sudeep, Chatterjee Sanjoy, Nigade Jagdish, Aggarwal Shyam, Singhal Manish, S S Alurkar, Kukreja Anil, B K Smruti, Nag Shona, Agarwal Amit, Agarwal Vijay, R T Chacko, Desai Chirag, Goswami Chanchal, Keechilat Pavithran, Patil Poonam, Prasad Krishna, Rajendranath Rejiv, R R Rao, T P Sahoo, Singh Ashish, Singh Randeep, Srinivasan Sankar, Warrier Arun, Swarup Binay, Bhattacharya Priyanka, S H Advani

Get full text